CONSULTING AGREEMENTConsulting Agreement • August 10th, 2022 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is dated May 3, 2022 and is effective as of July 3, 2022 (the “Effective Date”) by and between Spero Therapeutics, Inc., with offices located at 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, together with its subsidiaries and affiliates (collectively, “Spero”) and Cristina Larkin (“Consultant”). Spero and Consultant shall be referred to individually as a “Party” and together as the “Parties”.
Cambridge, MA 02139 May 3, 2022 Ms. Cristina Larkin Dear Cristina:Severance Agreement • August 10th, 2022 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
As was discussed with you, your employment with Spero Therapeutics, Inc. (the "Company") is ending. This letter is to summarize the terms of the separation package that the "Company is willing to offer you as a result of your separation from employment. Please read this letter agreement (the “Letter Agreement”), which includes a general release, carefully. If you are willing to agree to its terms, please sign in the space provided below and return it to me so that your separation benefits can begin.
Cambridge, MA 02139 May 3, 2022 Dr. David Melnick Dear David:Severance Agreement • August 10th, 2022 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
As was discussed with you, your employment with Spero Therapeutics, Inc. (the "Company") is ending. This letter is to summarize the terms of the separation package that the "Company is willing to offer you as a result of your separation from employment. Please read this letter agreement (the “Letter Agreement”), which includes a general release, carefully. If you are willing to agree to its terms, please sign in the space provided below and return it to me so that your separation benefits can begin.
